Latest filing published 13 Mar 2025 for Solid Biosciences Inc., €9,156.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +47.0%Entry US$5.09 · Close at T+365 US$7.48
- -42.2%Entry US$7.93 · Close at T+365 US$4.58
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Clare Kahn: trading record in brief
All filings by Clare Kahn on record concern Solid Biosciences Inc. Over a trading history stretching from 7 June 2024 to 11 March 2025, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €17k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at 1 purchase and no sales.
The record was last updated on 13 March 2025 with an open-market purchase (€9,156) in Solid Biosciences Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Clare Kahn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,860 shares@ US$5.335754.2% of flowCommon StockSEC:0000950170-25-038706:0Canonical exit: 9 Jun 2025 (T+90)
- 1,100 shares@ US$7.674245.8% of flowCommon StockSEC:0000950170-24-071765:0Canonical exit: 5 Sept 2024 (T+90)
2 of 2 declarations
